z-logo
Premium
Ranitidine kinetics and dynamics: II. Intravenous dose studies and comparison with cimetidine
Author(s) -
Lebert P A,
Mahon W A,
MacLeod S M,
Soldin S J,
Fenje P,
Vandenberghe H M
Publication year - 1981
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.1981.201
Subject(s) - cimetidine , ranitidine , medicine , kinetics , pharmacology , quantum mechanics , physics
Intravenous ranitidine has been shown to reduce pentagastrin‐stimulated gastric secretion. Eight normal men received, in randomized order, 60 mg ranitidine or 300 mg cimetidine intravenously over 2 min. Both ranitidine and cimetidine induced decreases in volume hydrogen ion content and pepsin activity of stimulated gastric juice. Ranitidine half‐life (t½) was 2.1 ± 0.1 hr and cimetidine (t½) was 1.5 ±0.1 hr. Ranitidine volume of distribution was 1.6 ±0.1 l/kg and that of cimetidine was 1.12 ± 0.12 l/kg. The clearance of ranitidine was 0.54 ± 0.04 l/kg hr −1 and that of cimetidine was 0.5 ± 0.05 l/kg hr −1 . It is suggested that the intravenous loading dose of ranitidine necessary to attain a serum concentration of 200 μg/l (which would achieve a 50% inhibition of gastric acid) is 0.3 mg/kg, followed by an infusion rate of 0.11 mg/kg hr −1 . Clinical Pharmacology and Therapeutics (1981) 30, 545–550; doi: 10.1038/clpt.1981.201

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom